Literature DB >> 11319176

Associations between ERCC2 polymorphisms and gliomas.

M Caggana1, J Kilgallen, J M Conroy, J K Wiencke, K T Kelsey, R Miike, P Chen, M R Wrensch.   

Abstract

Xeroderma pigmentosum complementation group D/excision repair cross-complementing in rodents 2 (ERCC2) encodes a protein that is part of the nucleotide excision repair pathway and the transcription factor IIH transcription complex. Mutations in this gene have been shown to cause three distinct clinical diseases including xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. Several ERCC2 polymorphisms, the effects of which on gene function are not known, have been described. To investigate whether constitutive sequence variations might be associated with adult onset gliomas, blood specimens from a case-control study (187 cases and 169 controls) were genotyped for seven previously described polymorphisms (R156R, I199M, H201Y, D312N, A575A, D711D, and K751Q). A novel R616C polymorphism was also identified. Cases were significantly more likely than controls to be homozygous for the silent AA variant at codon 156 (odds ratio, 2.3; 95% confidence interval, 1.3-4.2). Although this was observed for patients in each of three histological subgroups of cases, (glioblastoma multiforme, astrocytoma, and oligoastrocytoma) compared with controls, the association was strongest for patients with oligoastrocytoma (odds ratio, 3.2; 95% confidence interval, 1.1-9.5). In contrast, cases were somewhat less likely than controls to carry variants at D312N, D711D, and K751Q, but not significantly so overall or for any subgroup after adjustment for age and gender. Individuals with variant nucleotides at D312N, D711D, and K751Q were significantly more likely to carry a variant at another of those three codons and less likely to carry a variant nucleotide at R156R, regardless of case or control status. Although the pattern of association observed here is consistent with a role of ERCC2 variants in the prevention or causation of glioma, these results are also consistent with the possibility that another gene linked to ERCC2 may be involved. This seems especially so because the strongest association was observed with a silent nucleotide variation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11319176

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  23 in total

Review 1.  Molecular epidemiology of primary brain tumors.

Authors:  Jun Gu; Yanhong Liu; Athanassios P Kyritsis; Melissa L Bondy
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

Review 2.  Polymorphisms in DNA Repair Gene and Susceptibility to Glioma: A Systematic Review and Meta-Analysis Based on 33 Studies with 15 SNPs in 9 Genes.

Authors:  Kun Liu; Yugang Jiang
Journal:  Cell Mol Neurobiol       Date:  2016-04-07       Impact factor: 5.046

3.  Complex association between ERCC2 gene polymorphisms, gender, smoking and the susceptibility to bladder cancer: a meta-analysis.

Authors:  Yuanyi Wu; Yong Yang
Journal:  Tumour Biol       Date:  2014-02-07

Review 4.  Association between DNA repair gene polymorphisms and risk of glioma: a systematic review and meta-analysis.

Authors:  Maral Adel Fahmideh; Judith Schwartzbaum; Paolo Frumento; Maria Feychting
Journal:  Neuro Oncol       Date:  2014-02-04       Impact factor: 12.300

5.  ERCC1 and ERCC2 polymorphisms and adult glioma.

Authors:  Margaret Wrensch; Karl T Kelsey; Mei Liu; Rei Miike; Michelle Moghadassi; Jennette D Sison; Kenneth Aldape; Alex McMillan; Joseph Wiemels; John K Wiencke
Journal:  Neuro Oncol       Date:  2005-10       Impact factor: 12.300

6.  HIF-1α genetic variants and protein expression confer the susceptibility and prognosis of gliomas.

Authors:  Liang Yi; Xuwei Hou; Ji Zhou; Lunshan Xu; Qing Ouyang; Hong Liang; Zhaocong Zheng; Hongjie Chen; Minhui Xu
Journal:  Neuromolecular Med       Date:  2014-06-15       Impact factor: 3.843

7.  Association between ERCC1 C8092A and ERCC2 K751Q polymorphisms and risk of adult glioma: a meta-analysis.

Authors:  Zhiqin Xu; Wenbin Ma; Lu Gao; Bing Xing
Journal:  Tumour Biol       Date:  2013-11-20

8.  Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans.

Authors:  Jeffrey S Chang; Margaret R Wrensch; Helen M Hansen; Jennette D Sison; Melinda C Aldrich; Charles P Quesenberry; Michael F Seldin; Karl T Kelsey; Rick A Kittles; Gabriel Silva; John K Wiencke
Journal:  Int J Cancer       Date:  2008-11-01       Impact factor: 7.396

9.  Polymorphisms of the XRCC1 and XPD genes and breast cancer risk: a case-control study.

Authors:  Lívia Kipikasová; Tomás Wolaschka; Peter Bohus; Helena Baumohlová; Juraj Bober; Jana Blazejová; Ladislav Mirossay; Marek Sarisský; Andrej Mirossay; Martina Cizmáriková; Dana Potoceková; Ján Mojzis
Journal:  Pathol Oncol Res       Date:  2008-04-16       Impact factor: 3.201

10.  Statistically significant association of the single nucleotide polymorphism (SNP) rs13181 (ERCC2) with predisposition to Squamous Cell Carcinomas of the Head and Neck (SCCHN) and Breast cancer in the north Indian population.

Authors:  Amit Kumar Mitra; Neetu Singh; Vivek Kumar Garg; Rashmi Chaturvedi; Mandira Sharma; Srikanta Kumar Rath
Journal:  J Exp Clin Cancer Res       Date:  2009-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.